Head of Department of Neurology

Terrassa Health Consortium (CST)

Consultant Neurologist

Delfos HM Hospital, CINAC, Private Hospital

Consultant Neurologist

Alomar Medical Centre

Associate Professor of Neurology

Gimbernat University

Associate Professor of Neurology

International University of Catalonia (UIC)

Consultant Neurologist

Barcelona Parkinson Manresa, Barcelona

Adjunct of Neurology

Mutua de Terrassa foundation

Fellowship in clinical and neurophysiology of Movement Disorders

University of Barcelona

1999

Postdoctoral fellowship in Movement Disorders and Parkinson disease

University of Barcelona

1998

Phd in Neurology

The Central University of Venezuela

1995

MD

University of Carabobo, Venezuela.

1990

Spanish Society of Neurology

Catalan Society of Neurology

Movement Disorders World Society

https://www.scirp.org/journal/articles.aspx?searchcode=Gabriel+Salazar++Tortolero&searchfield=authors&page=1

G. Salazar; et al. "Post infectious Opsoclinus-Myoclonus syndrome in a Cov-2 infected patient". EC Neurology, 12.9 (2020) 99-101

G.Salazar(www.barcelonaparkinson.com) . J. Badia ( Teracat) Application for self evaluation in Parkinson's disease patients: MiParkinson ( Android and IOS).

Gabriel Salazar, Marta Fragoso, Jonatan Martí, Noelia Martín, Rosó Bernal. Continuous Apomorphine Infusion in Patients with Advanced Parkinson’s Disease with Varying Degrees of functional impairment. Journal of Behavioral and Brain Science, 2016, 6,393-403.http://www.scirp.org/journal/jbb

G. Salazar. M.Fragoso. M. Font. Apomorphine in pump for advaced PD patients with different functional disability. Neurologia April 2016.

Francesc Vallderiola,1,2 Yaroslau Compta,1,2 Javier Aparicio,3 Jaume Tarradellas,4 Gabriel Salazar,5 et al.Effects of Night-Time Use of Rotigotine on Nocturnal Symptoms in Parkinson’s Disease.Parkinson’s Disease.Volume 2015 (2015), Article ID 475630, 6

Salazar G, Fragoso M, Rey A, Sánchez L, Navarro MG (2014) IncobotulinumtoxinA (Xeomin®) and OnabotulinumtoxinA (Botox®) for Chronic Migraine Headache: Experience with Higher Doses and Changes to the Injection Technique. J Neurol Disord 2:192. doi: 10.4172/2329-6895.100019.

Salazar G, Fragoso M and Rey A. Lower Body Parkinsonism Patients: Increased Blood Flow in Posterior Cerebral Arteries. Austin J Neurol Disord Epilepsy. 2014; 1(2): 1008.

Salazar G, Fragoso M, Espanol G, Estevez M, Rey A (2015) EEG Findings in Diffuse Lewy Body Disease and Parkinson ́S Disease with Dementia. Brain Disord Ther 4: 156. doi:10.4172/2168-975X.10001

Salazar G. Neuropsychiatric symptoms in Lewy body diffuse disease: a case report. Neurologia 26:499 (2011)

Oromandibular dystonia secondary to radiotherapy. Peripheral injuries triggering thalamic disruption?: A case report. G. Salazar et al. / Basal Ganglia 1 (2011) 235–236

Metoclopramide as a painkiller in acute migraine attacks: CNS drugs and therapy : Recent Patents on CNS Drug Discovery, Volume 6, Number 2, May 2011 , pp. 141-145(5)

Ocullo-Jaw-Lingual synkinesia in PD, MSA and normal subjects. Clinical neutro physiology 121 (2010) 94-97

Amnesia global secundaria a un hematoma espontáneo del cuerpo calloso: A propósito de un caso. Med clin (Barc).2009. May 7

Metoclopramida como analgesico en la cefalea migrañosa intensa en urgencias., Rev. Neurol 2008, 47 (10) 506-508

Baclofeno intratecal en la Distonia generalizada secundaria a una Hipoxia cerebral. Rev. Neurol 2008; 47 (I) pag.53

Eficacia y Tolerancia del Piribedil como terapia adjunta a la l-dopa en Pacientes con enf. De Parkinson: Rev Neurol. 2004 Apr 16-30; 38(8):715-9

Postural and Action Myoclonus in Patients with Parkinsonian Type Multi System Atrophy. MOV. Dis. Vol. 15 n 1, 2000, pp 77-83.

Bladder dysfunction in progressive supranuclear palsy and other parkinsonian disorders. -European neurological societies June 1997 en Rhodas-Grece.

Postural and action myoclonus in patients with parkinsonian type multiple system atrophy Mov. Dis. Volume 15 Issue 1, Pages 77-83